Skip to main content
Karo Pharma AB logo

Karo Pharma AB — Investor Relations & Filings

Ticker · KARO ISIN · SE0007464888 LEI · 213800G54Z51LOPGTA79 ST Manufacturing
Open in API
Filings indexed 653 across all filing types
Latest filing 2014-05-13 Major Shareholding Noti…
Country SE Sweden
Listing ST KARO

About Karo Pharma AB

https://www.karohealthcare.com/

Karo Pharma AB, operating as Karo Healthcare, is a healthcare company that develops, markets, and sells a broad portfolio of everyday healthcare products. The company's offerings are designed to prevent illness and treat common health problems, empowering consumers to manage their daily well-being. The portfolio consists of various branded medicines and consumer healthcare products distributed through pharmacies and directly to healthcare providers. With products available in over 90 countries, the company focuses on becoming a leading force in its sector by employing a consumer-centric approach, strategic innovation, and omnichannel excellence.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2014
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for a specific holder (Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension) in Karo Healthcare AB. It explicitly states the 'Reason for major shareholding notification Sell' and provides 'Before the transaction' and 'After the transaction' figures, culminating in a new percentage of 9.95%. This structure perfectly matches the definition of a Major Shareholding Notification, which is classified as 'MRQ'. The document is short and contains the final notification data, not an announcement about a report.
2014-05-13 English
Annual General Meeting 2014 in Karo Bio AB
AGM Information Classification · 99% confidence The document explicitly states it contains the resolutions passed at the 'Annual General Meeting 2014 in Karo Bio AB'. It details voting outcomes on financial statements, board member elections, auditor re-election, remuneration guidelines, and authorization for future share issues. This content directly corresponds to the materials and outcomes of an AGM. Therefore, the appropriate classification is AGM Information (AGM-R). The document length (3264 chars) is substantial enough to be the primary report of the meeting's results, not just a brief announcement of a report.
2014-05-08 English
Årsstämma 2014 i Karo Bio AB
AGM Information Classification · 98% confidence The document is titled "PRESSMEDDELANDE" (Press Release) and details the key decisions made during the "Årsstämma 2014 i Karo Bio AB" (Annual General Meeting 2014 in Karo Bio AB). The content covers the approval of financial statements, decisions on dividend (none declared), election/re-election of board members, approval of director remuneration, reappointment of the auditor, and authorization for future share issuance. These are all typical resolutions passed at an Annual General Meeting (AGM). Since the document summarizes the decisions made *at* the meeting rather than being a proxy statement (PSI) or a formal voting result declaration (DVA), the most appropriate classification is AGM Information (AGM-R). The document length (3218 chars) is short, but it is the primary report of the meeting outcomes, not just an announcement that the meeting occurred or that materials are available.
2014-05-08 Swedish
Major Shareholding Notification 2014
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for a specific holder (Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension) in Karo Healthcare AB. It explicitly states the 'Reason for major shareholding notification Buy' and provides 'Before the transaction' and 'After the transaction' figures, including the new percentage (10.08%). This structure perfectly matches the definition of a Major Shareholding Notification, which is categorized as 'MRQ'. The document length is short (2479 chars), but its content is the notification itself, not an announcement of a report.
2014-05-08 English
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 100% confidence The document is titled 'DELÅRSRAPPORT JANUARI-MARS 2014' (Interim Report January-March 2014). It contains comprehensive financial statements, including income statements, cash flow analysis, and management commentary on business performance for the first quarter of 2014. It is not a mere announcement of a report, but the report itself, containing substantive financial data. Q1 2014
2014-05-08 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT JANUARY-MARCH 2014' and contains comprehensive financial statements, including consolidated earnings, cash flow, financial position, and key financial data tables for the specified period. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2014
2014-05-08 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.